Journal of the National Comprehensive Cancer Network · 2016 · 343 citations · 61 references
MedicineOncologyUrologyCancer ScreeningEarly DetectionGenitourinary OncologyCancer Early DetectionCancer SurveillanceEarly Cancer DetectionPopulation ScreeningProstate BiopsyProstate CancerBiopsy AccuracyBiopsy Technique OptimizationClinical Practice Guidelines ImplementationHigh-risk Patient PopulationsPreoperative Patient SelectionProstate Cancer DiagnosisProstate ScreeningRisk Stratification For Biopsy
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.
61
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole, E. David Crawford, Robert L. Grubb et al. · New England Journal of Medicine · 2009 · 2.9K citations · Full text
Risks of cancer in BRCA1-mutation carriers
Daniel Ford · The Lancet · 1994 · 1.9K citations
Life Sciences, Genetics, Oncology +12
Cancer Risks in BRCA2 Mutation Carriers
JNCI Journal of the National Cancer Institute · 1999 · 1.5K citations · Full text